CJC-1295/Ipamorelin is a research peptide combination pairing a GHRH (growth hormone-releasing hormone) analog with a selective GHRP (growth hormone-releasing peptide). Researchers studying the growth hormone axis often work with this pairing because CJC-1295 and Ipamorelin act on two different receptor pathways that are frequently examined together in pulsatile secretion studies. Each vial from Helix Bio is synthesized to a high purity standard and verified before it ships, with a Certificate of Analysis available for every lot. This product is manufactured strictly for laboratory research and is not intended for human or animal use.
HPLC certified
Independent analysis
Highest standard
Full traceability
CJC-1295 and Ipamorelin are two distinct synthetic peptides that are frequently studied in combination because they engage complementary pathways in growth hormone regulation. CJC-1295 is a GHRH analog, meaning its amino acid sequence is modeled after the natural growth hormone-releasing hormone produced by the hypothalamus. Ipamorelin belongs to a separate peptide class, the GHRPs, and is recognized in the research literature for its high selectivity at the ghrelin receptor with comparatively little effect on cortisol, prolactin, or appetite-related hormones relative to older GHRPs such as GHRP-6.
When supplied as a blend, both peptides are lyophilized together (or packaged as a matched pair, depending on the format ordered) so that researchers designing in-vitro or non-clinical study protocols can work with a consistent, pre-paired research reagent rather than sourcing and combining two separate vials themselves.
Each vial contains synthetic CJC-1295 and synthetic Ipamorelin in lyophilized powder form. No fillers, preservatives, or carrier proteins are added beyond what is required for stable lyophilization. Exact peptide content per vial (for example, 2mg or 5mg configurations) is listed on the individual product listing and confirmed on the batch-specific Certificate of Analysis.
This product is intended exclusively for laboratory research, including in-vitro assays, non-clinical study protocols, and educational demonstrations conducted by qualified professionals. It is not formulated, labeled, or approved for human consumption, veterinary use, or any therapeutic application.
Researchers comparing suppliers generally look for three things: verifiable purity, consistent batch quality, and clear documentation. Helix Bio structures this listing around all three. Every lot is tested before it ships, the resulting Certificate of Analysis is made available on request, and the product is labeled and packaged specifically for research use rather than marketed as a consumer wellness product. For labs already working with CJC-1295 and Ipamorelin separately, the blend format also removes a step from protocol preparation by supplying both peptides together in a single, traceable listing.
This listing is intended for:
It is not intended for individual consumers seeking a product for personal, therapeutic, or performance use.
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Cyclic peptides resist protease degradation and reach undruggable targets. Learn how peptide cyclization works and why stability improves. Explore the research.
How continuous flow, automation, enzymatic routes and AI are changing peptide synthesis technology, and what it means for research peptide purity and supply.
AI now designs peptides from scratch. How AlphaFold 3, RFdiffusion and protein language models reshaped peptide discovery in 2026 — research use only.
